Free Newsletter
NIAID budgets $161M for flu research
The National Institute of Allergy and Infectious Diseases will spend $23 million a year over the next seven years to establish a consortium of six research centers to investigate influenza viruses--including H5N1. The goal is to help government officials respond to seasonal flu as well as potential outbreaks of pandemics.
"There are a variety of viruses to monitor besides the well-known H5N1," St. Jude researcher Robert Webster said. "For example, H7N7 infected chicken industry workers in the Netherlands; and H9N2, which circulates in many global avian populations, also sporadically appears in humans."
The six centers and their primary researchers are: St. Jude Children's Research Hospital; University of California at Los Angeles; University of Minnesota, Minneapolis; Emory University, Atlanta; Mount Sinai School of Medicine, New York and the University of Rochester, Rochester, N.Y.
- check out the release on the funding
Related Articles:
NIAID finds antibodies that neutralize H5N1. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: